SEC Form D · Amendment · filed December 13, 2017
Neon Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
Robert Ang, M.D · Cambridge, MAExecHugh Dowd · Cambridge, MAExec · DirectorRobert Tepper · Cambridge, MADirectorCary Pfeffer, M.D · Cambridge, MADirectorRichard Gaynor, M.D · Cambridge, MAExecRobert Kamen · Cambridge, MADirectorEric Lander · Cambridge, MADirectorStephen Sherwin · Cambridge, MADirectorEdmund Hannon · Suffern, NYDirectorRooksana Shahabally · Port Louis, O4DirectorHusayn Sassa · Port Louis, O4ExecRajiv Seetul · Port Louis, O4DirectorKevin Solomon · GRAND CAYMAN, Cayman IslandsExecBashir Nabeebokus · Port Louis, O4Exec · DirectorElie Rieder · Suffern, NYDirectorDeven Coopoosamy · Port Louis, O4DirectorYasir Al-Wakeel · Cambridge, MAExecHaroon L. Ismail · New York, NYDirectorLouis Sharpe · New York, NYDirectorEric Jungbluth · New York, NYExec · DirectorJason Cawley · New York, NYExecChristopher Nagel · New York, NYDirectorWilliam H. Parkerson · Overland Park, KSDirectorJohn A. Meltzer · New Orleans, LADirectorMartha N. Solomon · New Orleans, LAExecYasir Al-Wakeel · Cambridge, MAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗